Our own meta-analysis confirmed elevated CSF neurogranin in Alzheimer’s disease and mild cognitive impairment, although other work suggests that neurogranin may not be entirely disease-specific [17,18]. This evidence concerns the gene NRGN and Alzheimer disease.